FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock
41.25 EUR
+0.11 (+0.27%)
Taking everything into account, FME scores 5 out of 10 in our fundamental rating. FME was compared to 27 industry peers in the Health Care Providers & Services industry. FME has an average financial health and profitability rating. FME has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
FME had positive earnings in the past year.
In the past year FME had a positive cash flow from operations.
FME had positive earnings in each of the past 5 years.
Each year in the past 5 years FME had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.33%, FME perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
FME has a Return On Equity of 5.55%. This is in the lower half of the industry: FME underperforms 66.67% of its industry peers.
FME's Return On Invested Capital of 3.95% is on the low side compared to the rest of the industry. FME is outperformed by 62.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.91%.
The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
With a Profit Margin value of 3.66%, FME perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
FME's Profit Margin has declined in the last couple of years.
FME has a Operating Margin (7.19%) which is comparable to the rest of the industry.
FME's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 25.00%, FME perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
FME has less shares outstanding than it did 5 years ago.
The debt/assets ratio for FME has been reduced compared to a year ago.
2.2 Solvency
FME has an Altman-Z score of 2.21. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
FME has a Altman-Z score (2.21) which is in line with its industry peers.
The Debt to FCF ratio of FME is 5.97, which is a neutral value as it means it would take FME, 5.97 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.97, FME is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
FME has a Debt to Equity ratio of 0.73. This is in the better half of the industry: FME outperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.21 |
ROIC/WACC0.7
WACC5.67%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
FME has a Current ratio of 1.36. This is in the better half of the industry: FME outperforms 66.67% of its industry peers.
A Quick Ratio of 1.00 indicates that FME may have some problems paying its short term obligations.
FME's Quick ratio of 1.00 is fine compared to the rest of the industry. FME outperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
The Earnings Per Share is expected to grow by 13.73% on average over the next years. This is quite good.
Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 4.08% on average per year.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.97 indicates a reasonable valuation of FME.
Based on the Price/Earnings ratio, FME is valued cheaper than 92.59% of the companies in the same industry.
FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 9.96, the valuation of FME can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 85.19% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. FME is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.97 | ||
| Fwd PE | 9.96 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FME is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.8 | ||
| EV/EBITDA | 10.69 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 13.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.50%.
Compared to an average industry Dividend Yield of 2.06, FME pays a better dividend. On top of this FME pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, FME pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/28/2025, 7:00:00 PM)
41.25
+0.11 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.21B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts65.6
Price Target48.43 (17.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.8%
PT rev (3m)-4.91%
EPS NQ rev (1m)-1.78%
EPS NQ rev (3m)-4.91%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.97 | ||
| Fwd PE | 9.96 | ||
| P/S | 1.23 | ||
| P/FCF | 13.8 | ||
| P/OCF | 9.64 | ||
| P/B | 1.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.69 |
EPS(TTM)3.76
EY9.12%
EPS(NY)4.14
Fwd EY10.04%
FCF(TTM)2.99
FCFY7.25%
OCF(TTM)4.28
OCFY10.37%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.6
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.21 |
F-Score5
WACC5.67%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.97 and the Price/Book (PB) ratio is 1.87.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 58.83%.